TMO
Thermo Fisher Scientific Inc.
$574.00
▼ -0.05%
−$0.30
NYSE · Healthcare · Diagnostics & Research
· price updated 9h ago
Thermo Fisher Scientific Inc.
TMO · NYSE · Healthcare · Diagnostics & Research · price updated 9h ago
$574.00
▼ -0.05% · −$0.30 today
AI research · $574.00
Track TMO for continuous AI research
price position
Where TMO sits now
52-week range
Low$405.15
High$643.99
Today $574.00
RSI (14)
74.9Overbought
03070100
fundamentals
Business quality and valuation
Operating record
What the business has actually produced
Revenue
Capital structure
Cash versus debt
Cash & investments$4.1B
Total debt$42.5B
Net cash after debt$-38.5B
Valuation
What the market charges
Forward P/E
Price against expected earnings
Middle ground · 6% above Sector avg
21.87x
Price / sales
Value assigned to each sales dollar
Reasonable · Between 3x and 8x sales
4.58x
Price / FCF
Price against free cash generation
Reasonable · Between 20x and 35x free cash flow
29.02x
EV / EBITDA
Operating value including debt
Rich · Above 22x EBITDA
24.42x
Quality
How efficiently it compounds
ROIC
Return earned on invested capital
Reasonable · An 8% to 15% return on capital
8.8%
ROE
Profit generated from shareholder equity
Middle ground · Roughly in line with sector
13.5%
Debt / equity
Balance-sheet leverage
Middle ground · Roughly in line with sector
0.81x
Current ratio
Short-term assets against liabilities
Strong · Comfortable short-term liquidity
1.55x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
peer comparison
How TMO compares
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $213.42B | 30.9 | +7.2% | 60 |
 | $10.69B | 18.4 | +23.5% | 78 |
 | $4.88B | 20.3 | +10.3% | 77 |
 | $31.49B | 32.9 | +15.5% | 77 |
 | $1.08T | 41.4 | +47.4% | 76 |
activity
What is moving TMO
US stock research
About Thermo Fisher Scientific Inc. (TMO) stock
Thermo Fisher Scientific Inc. tracked in the US core universe. TMO was -0.1% in the latest available session at $574.00. Its reported market value was $213.42B with a trailing P/E of 30.9. Latest reported revenue was $46.34B, changing +7.2% year over year, with $6.97B in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.
- Latest available price
- $574.00
- Day change
- -0.1%
- Market cap
- $213.42B
- P/E (TTM)
- 30.9
- Revenue growth
- +7.2%
- Industry
- Diagnostics & Research